| Followers | 142 |
| Posts | 20132 |
| Boards Moderated | 9 |
| Alias Born | 05/28/2009 |
Tuesday, October 25, 2011 4:04:53 PM
I respecfully disagree gm. What clearly appears to be the case here today, is that someone entered a limit order to buy 50,000 shares at the stated ask of .09, only got a fill on the 45,000 shares offered, and that person is now the bid at .09 for the remaining 5,000 shares of their order. At least, that is how it appears to me, as I ofeten get only a partial fill on limit orders for CTYX and then become the bid.
I understand that you have a lot of hard feelings over whatever happened here before, but I do not think your negative suspicion is right this time.
P.S. have you ever considered firing at CTYX on the dips to seriously average down your cost per share. It would seem to me that, if you have a cost average up near .09 or .10, that you could significantly lowere your avg. PPS if you bought significant blocks of shares down around .05 - .07 when the dips occur. I really do believe that this stock will see the .03 - .05 range within the next 6-12 months.
I understand that you have a lot of hard feelings over whatever happened here before, but I do not think your negative suspicion is right this time.
P.S. have you ever considered firing at CTYX on the dips to seriously average down your cost per share. It would seem to me that, if you have a cost average up near .09 or .10, that you could significantly lowere your avg. PPS if you bought significant blocks of shares down around .05 - .07 when the dips occur. I really do believe that this stock will see the .03 - .05 range within the next 6-12 months.
Recent CUBT News
- Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement • GlobeNewswire Inc. • 05/07/2026 11:00:00 AM
- Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy • GlobeNewswire Inc. • 04/15/2026 12:08:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:05:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Curative Biotechnology Announces Canadian Patent Allowance • GlobeNewswire Inc. • 01/23/2026 01:45:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 12/22/2025 06:40:01 PM
- Curative Biotechnology, Inc. Announces Letter to Shareholders • GlobeNewswire Inc. • 11/18/2025 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/01/2025 08:07:47 PM
